6 tips for early-stage MDx companies seeking successful commercialization

In this interview, experienced advisors, Harry Glorikan, general partner at New Ventures Funds, and Sébastien Chapdelaine, Senior Director of R&D at a molecular diagnostics start-up company, discuss their top tips for how early-stage companies can find and choose the best suppliers, with notes on maximizing the relationship and mitigating risk.